{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:41:39Z","timestamp":1792503699340,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012891","name":"Medical Research Charities Group","doi-asserted-by":"publisher","award":["MR\/P008399\/1"],"award-info":[{"award-number":["MR\/P008399\/1"]}],"id":[{"id":"10.13039\/100012891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V02552X\/1"],"award-info":[{"award-number":["MR\/V02552X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013560","name":"GBS\/CIDP Foundation International","doi-asserted-by":"publisher","award":["1709HM001\/SB17"],"award-info":[{"award-number":["1709HM001\/SB17"]}],"id":[{"id":"10.13039\/100013560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Membranous glomerulonephritis (MGN) is a common cause of nephrotic syndrome in adults, mediated by glomerular antibody deposition to an increasing number of newly recognised antigens. Previous case reports have suggested an association between patients with anti-contactin-1 (CNTN1)-mediated neuropathies and MGN. In an observational study we investigated the pathobiology and extent of this potential cause of MGN by examining the association of antibodies against CNTN1 with the clinical features of a cohort of 468 patients with suspected immune-mediated neuropathies, 295 with idiopathic MGN, and 256 controls. Neuronal and glomerular binding of patient IgG, serum CNTN1 antibody and protein levels, as well as immune-complex deposition were determined. We identified 15 patients with immune-mediated neuropathy and concurrent nephrotic syndrome (biopsy proven MGN in 12\/12), and 4 patients with isolated MGN from an idiopathic MGN cohort, all seropositive for IgG4 CNTN1 antibodies. CNTN1-containing immune complexes were found in the renal glomeruli of patients with CNTN1 antibodies, but not in control kidneys. CNTN1 peptides were identified in glomeruli by mass spectroscopy. CNTN1 seropositive patients were largely resistant to first-line neuropathy treatments but achieved a good outcome with escalation therapies. Neurological and renal function improved in parallel with suppressed antibody titres. The reason for isolated MGN without clinical neuropathy is unclear. We show that CNTN1, found in peripheral nerves and kidney glomeruli, is a common target for autoantibody-mediated pathology and may account for between 1 and 2% of idiopathic MGN cases. Greater awareness of this cross-system syndrome should facilitate earlier diagnosis and more timely use of effective treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0281156","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T18:37:21Z","timestamp":1678387041000},"page":"e0281156","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-5708","authenticated-orcid":true,"given":"Janev","family":"Fehmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Antonelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Keddie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pikkupeura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilien","family":"Delmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-4383","authenticated-orcid":true,"given":"Filipa","family":"Farinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Canetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel B.","family":"Rendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Radunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Minton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling S.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Eftimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk","family":"Wieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S. D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"pone.0281156.ref001","doi-asserted-by":"crossref","first-page":"204800401667768","DOI":"10.1177\/2048004016677687","article-title":"Neurological complications in chronic kidney disease.","volume":"5","author":"R Arnold","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"key":"pone.0281156.ref002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.ajkd.2009.10.050","article-title":"The Management of Diabetic Neuropathy in CKD","volume":"55","author":"R Pop-Busui","year":"2010","journal-title":"American Journal of Kidney Diseases"},{"key":"pone.0281156.ref003","first-page":"485","article-title":"Star fruit: Simultaneous neurotoxic and nephrotoxic effects in people with previously normal renal function.","volume":"2","author":"MM Neto","year":"2009","journal-title":"NDT Plus"},{"key":"pone.0281156.ref004","volume-title":"Clinical Microbiology and Infection","author":"F Wagenlehner","year":"2021"},{"key":"pone.0281156.ref005","doi-asserted-by":"crossref","first-page":"c43","DOI":"10.1159\/000320903","article-title":"Blood Pressure, Proteinuria and Nephropathy in Fabry Disease.","volume":"118","author":"G Jain","year":"2011","journal-title":"Nephron Clin Pract."},{"key":"pone.0281156.ref006","first-page":"1","volume-title":"European Journal of Paediatric Neurology","author":"S de Rechter","year":"2015"},{"key":"pone.0281156.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"LH Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0281156.ref008","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy","volume":"371","author":"NM Tomas","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"pone.0281156.ref009","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"WG Couser","year":"2017","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"pone.0281156.ref010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.","volume":"9","author":"Y Hashimoto","year":"2018","journal-title":"Front Neurol"},{"key":"pone.0281156.ref011","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"K Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0281156.ref012","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"E Delmont","year":"2017","journal-title":"Brain"},{"key":"pone.0281156.ref013","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cNeuro-renal syndrome\u201d related to anti-contactin-1 antibodies.","volume":"59","author":"G Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"pone.0281156.ref014","doi-asserted-by":"crossref","first-page":"102308","DOI":"10.1016\/j.jaut.2019.102308","article-title":"Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain","volume":"106","author":"M Fresquet","year":"2020","journal-title":"J Autoimmun"},{"key":"pone.0281156.ref015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/brain\/awx012","article-title":"Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination","volume":"140","author":"AJ Clark","year":"2017","journal-title":"Brain"},{"key":"pone.0281156.ref016","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nbt.2249","article-title":"Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors","volume":"30","author":"SM Chambers","year":"2012","journal-title":"Nat Biotechnol"},{"key":"pone.0281156.ref017","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1515\/cclm-2019-1007","article-title":"Diagnostic amyloid proteomics: Experience of the UK National Amyloidosis Centre","volume":"58","author":"D Canetti","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"pone.0281156.ref018","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001040","article-title":"Serum Contactin-1 in CIDP A Cross-Sectional Study Class of Evidence Criteria for rating therapeutic and diagnostic studies.","volume":"8","author":"L Wieske","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"pone.0281156.ref019","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of Immune Complex Size and Glycosylation on IgG Binding to Human Fc\u03b3Rs","volume":"190","author":"A Lux","year":"2013","journal-title":"The Journal of Immunology"},{"key":"pone.0281156.ref020","author":"PYK van den Bergh","journal-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher."},{"key":"pone.0281156.ref021","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.","volume":"7","author":"A Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"pone.0281156.ref022","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/cjn.2020.46","article-title":"Chronic Inflammatory Demyelinating Polyneuropathy and Concurrent Membranous Nephropathy","volume":"47","author":"S Nazarali","year":"2020","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"pone.0281156.ref023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0270-9295(03)00049-4","article-title":"Diagnosis and natural course of membranous nephropathy.","volume":"23","author":"RJ Glassock","year":"2003","journal-title":"Semin Nephrol."},{"key":"pone.0281156.ref024","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"L Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"pone.0281156.ref025","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.kint.2021.08.029","article-title":"Contactin-1\u2013associated membranous nephropathy: complete immunologic and clinical remission with rituximab","volume":"100","author":"E Plaisier","year":"2021","journal-title":"Kidney Int"},{"key":"pone.0281156.ref026","doi-asserted-by":"crossref","first-page":"e110681","DOI":"10.1371\/journal.pone.0110681","article-title":"PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.","volume":"9","author":"E Hoxha","year":"2014","journal-title":"PLoS One."},{"key":"pone.0281156.ref027","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"LH Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"pone.0281156.ref028","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1681\/ASN.2019050538","article-title":"Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy","volume":"31","author":"PD Burbelo","year":"2020","journal-title":"Journal of the American Society of Nephrology"},{"key":"pone.0281156.ref029","first-page":"1461","article-title":"Spatiotemporal immune zonation of the human kidney","volume":"365","author":"BJ Stewart","year":"2019","journal-title":"Science (1979)."},{"key":"pone.0281156.ref030","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"M le Quintrec","year":"2021","journal-title":"Kidney Int"},{"key":"pone.0281156.ref031","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fimmu.2019.01809","article-title":"Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.","author":"W Liu","year":"2019","journal-title":"Frontiers in immunology. NLM (Medline)"},{"key":"pone.0281156.ref032","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","author":"M Nangaku","year":"2005","journal-title":"Clinical and Experimental Nephrology. Clin Exp Nephrol"},{"key":"pone.0281156.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1980.1","article-title":"In situ immune complex formation and glomerular injury","volume":"17","author":"WG Couser","year":"1980","journal-title":"Kidney Int"},{"key":"pone.0281156.ref034","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: Recent advances and future challenges","author":"P Ronco","year":"2012","journal-title":"Nature Reviews Nephrology"},{"key":"pone.0281156.ref035","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"C Manso","year":"2016","journal-title":"Brain"},{"key":"pone.0281156.ref036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-019-1462-z","article-title":"Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model.","volume":"16","author":"K Doppler","year":"2019","journal-title":"J Neuroinflammation."},{"key":"pone.0281156.ref037","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/ndt\/gfq708","article-title":"Mindin: a novel marker for podocyte injury in diabetic nephropathy.","volume":"26","author":"M Murakoshi","year":"2011","journal-title":"Nephrol Dial Transplant. 2010"},{"key":"pone.0281156.ref038","first-page":"2018","article-title":"Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management","author":"A Pozdzik","year":"2018","journal-title":"Biomed Res Int"},{"key":"pone.0281156.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.574208","article-title":"The Role of Contactin 1 in Cancers: What We Know So Far.","volume":"10","author":"Y Liang","year":"2020","journal-title":"Front Oncol."},{"key":"pone.0281156.ref040","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"C Lefaucheur","year":"2006","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T18:38:02Z","timestamp":1678387082000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281156"}},"subtitle":[],"editor":[{"given":"Zhanjun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281156","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}